Diurnal differences in acute gout attacks: A clinical study of male gout patients

  • Hong DONG ,
  • Li-min WANG ,
  • Zhi-qiang WANG ,
  • Yan-qing LIU ,
  • Xiao-gang ZHANG ,
  • Ming-ming ZHANG ,
  • Juan LIU ,
  • Zhen-bin LI
Expand
  • 1. Department of Rheumatology and Immunology, PLA Joint Logistic Support Force No.980 Hospital, Shijiazhuang 050082, China
    2. The Graduate School, Hebei Medical University, Shijiazhuang 050011, China

Received date: 2022-08-16

  Online published: 2023-10-09

Supported by

the Key Research & Development Project of Hebei Province(20377713D)

Abstract

Objective: To observe the diurnal difference of acute gout attacks in men, and provide reference for accurate clinical prevention and treatment. Methods: Using a single-center, cross-sectional study design, the patients diagnosed with gout in the outpatient department of Rheumatology and Immuno-logy of PLA Joint Logistic Support Force No.980 Hospital from October 2021 to April 2022 were selected. The information about the patient's current/last acute gout attacks (less than 2 weeks from visit), date and time of attacks, joint symptoms and signs, medication use, and relevant biochemical tests on the day of visit was recorded. The diurnal time difference of acute gout attacks in male patients was analyzed, and univariate comparison and multivariate Logistic regression analyses were conducted to compare the diurnal difference of acute gout attacks with clinical characteristics and biochemical indicators. Results: A total of 100 male gout patients were included, and 100 acute attacks were recorded. Diurnal distribution of acute gout attacks: morning (6:00~11:59, 18, 18%), afternoon (12:00~17:59, 11, 11%), the first half of the night (18:00~23:59, 22, 22%), the second half of the night (0:00~05:59, 49, 49%); During the day (included morning and afternoon, 29, 29%) and at night (included the first half of the night and the second half of the night, 71, 71%). The rate of acute gout attack was significantly higher at night than in the day (about 2.5 ∶1). No matter the first or recurrent gout, no matter the duration of the disease, the number of acute gout attacks had the difference of less in the day and more in the night. Serum urate (SU) level was higher in the patients with nocturnal attack than in those with daytime attack (P=0.044). Comorbidities were significantly different in the day-night ratio of the number of acute gout attack (P=0.028). Multiple Logistic regression analysis showed that SU level (OR=1.005, 95%CI: 1.001-1.009) and comorbidities (OR=3.812, 95%CI: 1.443-10.144) were the correlative factors of nocturnal acute gout attacks. Conclusion: No matter the first or recurrent gout, no matter the duration of the disease, it has a diurnal variation characterized by multiple attacks at night, increased SU level and comorbidities are correlative factors for nocturnal acute attack of gout.

Cite this article

Hong DONG , Li-min WANG , Zhi-qiang WANG , Yan-qing LIU , Xiao-gang ZHANG , Ming-ming ZHANG , Juan LIU , Zhen-bin LI . Diurnal differences in acute gout attacks: A clinical study of male gout patients[J]. Journal of Peking University(Health Sciences), 2023 , 55(5) : 915 -922 . DOI: 10.19723/j.issn.1671-167X.2023.05.021

References

1 Singh JA , Gaffo A . Gout epidemiology and comorbidities[J]. Semin Arthritis Rheum, 2020, 50 (Suppl 3): 11- 16.
2 Choi HK , Mount DB , Reginato AM . Pathogenesis of gout[J]. Ann Intern Med, 2005, 143 (7): 499- 516.
3 Li Q , Li X , Wang J , et al. Diagnosis and treatment for hyperuricemia and gout: A systematic review of clinical practice guidelines and consensus statements[J]. BMJ Open, 2019, 9 (8): e026677.
4 Allada R , Bass J . Circadian mechanisms in medicine[J]. N Engl J Med, 2021, 384 (6): 550- 561.
5 Ursini F , Giorgi AD , D'Onghia M , et al. Chronobiology and chronotherapy in inflammatory joint diseases[J]. Pharmaceutics, 2021, 13 (11): 1832- 1834.
6 Early JO , Menon D , Wyse CA , et al. Circadian clock protein BMAL1 regulates IL-1β in macrophages via NRF2[J]. Proc Natl Acad Sci USA, 2018, 115 (36): E8460- E8468.
7 Scheiermann C , Gibbs J , Ince L , et al. Clocking in to immunity[J]. Nat Rev Immunol, 2018, 18 (7): 423- 437.
8 Choi HK , Niu J , Neogi T , et al. Nocturnal risk of gout attacks[J]. Arthritis Rheumatol, 2015, 67 (2): 555- 562.
9 Gaffo AL , Dalbeth N , Saag KG , et al. Brief report: Validation of a definition of flare in patients with established gout[J]. Arthritis Rheumatol, 2018, 70 (3): 462- 467.
10 García D , Armengol NS , Crespo EL , et al. Blood uric acid levels in patients with sleep-disordered breathing[J]. Arch Bronconeumol, 2006, 42 (10): 492- 500.
11 P?ywaczewski R , Bednarek M , Jonczak L , et al. Hyperuricaemia in males with obstructive sleep apnoea (OSA)[J]. Pneumonol Alergol Pol, 2005, 73 (3): 254- 259.
12 Chou YT , Chuang LP , Li HY , et al. Hyperlipidaemia in patients with sleep-related breathing disorders: prevalence & risk factors[J]. Indian J Med Res, 2010, 131, 121- 125.
13 Abrams B . High prevalence of gout with sleep apnea[J]. Med Hypotheses, 2012, 78 (2): 349- 351.
14 Roddy E , Muller S , Hayward R , et al. The association of gout with sleep disorders: A cross-sectional study in primary care[J]. BMC Musculoskelet Disord, 2013, 14 (1): 119- 124.
15 Dalbeth N , Gosling AL , Gaffo A , et al. Gout[J]. Lancet, 2021, 397 (10287): 1843- 1855.
16 Kanabrocki , Eugene L . Circadian relationship of serum uric acid and nitric oxide[J]. JAMA, 2000, 283 (17): 2240- 2241.
17 Kanabrocki EL , Murray D , Hermida RC , et al. Circadian variation in oxidative stress markers in healthy and type Ⅱ diabetic men[J]. Chronobiol Int, 2002, 19 (2): 423- 439.
18 Kanabrocki EL , Ryan M , Hermida RC , et al. Altered circadian relationship between serum nitric oxide, carbon dioxide, and uric acid in multiple Sclerosis[J]. Chronobiol Int, 2004, 21 (4/5): 739- 758.
19 Devgun MS , Dhillon HS . Importance of diurnal variations on clinical value and interpretation of serum urate measurements[J]. J Clin Pathol, 1992, 45 (2): 110- 113.
20 Selmaoui B , Lambrozo J , Touitou Y . Assessment of the effects of nocturnal exposure to 50 Hz magnetic fields on the human circadian system. A comprehensive study of biochemical variables[J]. Chronobiol Int, 1999, 16 (6): 789- 810.
21 Morrison B , Shenkin A , Mclelland A , et al. Intra-individual variation in commonly analyzed serum constituents[J]. Clin Chem, 1979, 25 (10): 1799- 1805.
22 Statland BE , Winkel P , Bokelund H . Factors contributing to intra-individual variation of serum constituents. 1. Within-day variation of serum constituents in healthy subjects[J]. Clin Chem, 1973, 19 (12): 1374- 1379.
23 Chagoya de Sánchez V , Hernández-Mu?oz R , Suárez J , et al. Temporal variations of adenosine metabolism in human blood[J]. Chronobiol Int, 1996, 13 (3): 163- 177.
24 Singh RK , Bansal A . Studies on circadian periodicity of serum and urinary urate in healthy Indians and renal stone formers[J]. Prog Clin Biol Res, 1987, 227, 305- 313.
25 Cameron M , Maalouf NM , Poindexter J , et al. The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers[J]. Kidney Int, 2012, 81 (11): 1123- 1130.
26 司可, 王颜刚. 尿酸排泄昼夜节律与尿酸结石[J]. 中华风湿病学杂志, 2021, 25 (10): 711- 714.
27 Harrison D , Bock MG , Doedens JR , et al. Discovery and optimization of triazolopyrimidinone derivatives as selective NLRP3 inflammasome inhibitors[J]. ACS Med Chem Lett, 2022, 13 (8): 1321- 1328.
28 Pourcet B , Zecchin M , Ferri L , et al. Nuclear receptor subfamily 1 group D member 1 regulates circadian activity of NLRP3 inflammasome to reduce the severity of fulminant hepatitis in mice[J]. Gastroenterology, 2018, 154 (5): 1449- 1464.
29 Pourcet B , Duez H . Circadian control of inflammasome pathways: Implications for circadian medicine[J]. Front Immunol, 2020, 11, 1630- 1642.
30 Avouac J , Gossec L , Dougados M . Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: A systematic literature review[J]. Ann Rheum Dis, 2006, 65 (7): 845- 851.
31 李振彬, 王自强. 中医时间用药法探讨[J]. 山东中医学院学报, 1988, 12 (2): 14-16, 73.
32 Smolensky MH , Portaluppi F , Manfredini R , et al. Diurnal and twenty-four hour patterning of human diseases: Cardiac, vascular, and respiratory diseases, conditions, and syndromes[J]. Sleep Med Rev, 2015, 21, 3- 11.
33 Riha RL . The use and misuse of exogenous melatonin in the treatment of sleep disorders[J]. Curr Opin Pulm Med, 2018, 24 (6): 543- 548.
Outlines

/